Related references
Note: Only part of the references are listed.Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-Lactamases
Sushmita D. Lahiri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae
Z. Aktas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Characterization of -lactamase and porin mutants of Enterobacteriaceae selected with ceftarolineavibactam (NXL104)
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Emergence of Ertapenem Resistance in an Escherichia coli Clinical Isolate Producing Extended-Spectrum β-Lactamase AmpC
Helene Guillon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
In vitro activity of the β-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases
Therese Stachyra et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Extension of the hydrolysis spectrum of AmpC β-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix
Hedi Mammeri et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Extended-spectrum cephalosporinases: structure, detection and epidemiology
Patrice Nordmann et al.
FUTURE MICROBIOLOGY (2007)
Naturally occurring extended-spectrum cephalosporinases in Escherichia coli
Hedi Mammeri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Characterization of bla(CMY-10) a novel, plasmid-encoded AmpC-type beta-lactamase gene in a clinical isolate of Enterobacter aerogenes
SH Lee et al.
JOURNAL OF APPLIED MICROBIOLOGY (2003)
Share Paper
